Alyeska Investment Group, L.P. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$17,210,000
+174.3%
100,000
+100.0%
0.21%
+195.8%
Q2 2021$6,275,000
-8.2%
50,000
-0.8%
0.07%
-18.2%
Q1 2021$6,838,000
+144.3%
50,423
-32.8%
0.09%
+319.0%
Q3 2017$2,799,000
+76.8%
75,000
+25.0%
0.02%
+40.0%
Q1 2016$1,583,000
+1.7%
60,000
-14.3%
0.02%
-76.6%
Q3 2013$1,556,00070,0000.06%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders